OncoFusion Therapeutics
About:
OncoFusion Therapeutics is engaged in the R&D of personalized therapeutics for patients with genetically defined cancers.
Website: http://oncofusion.com
Description:
OncoFusion Therapeutics Inc. discovers and develops personalized therapeutics for patients with genetically defined cancers. It focuses on bromodomain inhibitors, ERG inhibitors, EZH-2-EED inhibitors, and MMSET/NSD 2 inhibitors. The company was founded in 2012 and is based in Ann Arbor, Michigan.
Total Funding Amount:
$525000
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Ann Arbor, Michigan, United States
Founded Date:
2012-01-01
Contact Email:
Bus-dev(AT)oncofusion.com
Founders:
Shaomeng Wang
Number of Employees:
1-10
Last Funding Date:
2013-03-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai